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Abstract
Complete atrioventricular canal (CAVC), also referred to as complete atrioventricular septal
defect, is characterised by an ostium primum atrial septal defect, a common atrioventricular valve
and a variable deficiency of the ventricular septum inflow. CAVC is an uncommon congenital heart
disease, accounting for about 3% of cardiac malformations. Atrioventricular canal occurs in two out
of every 10,000 live births. Both sexes are equally affected and a striking association with Down
syndrome was found. Depending on the morphology of the superior leaflet of the common
atrioventricular valve, 3 types of CAVC have been delineated (type A, B and C, according to
Rastelli's classification). CAVC results in a significant interatrial and interventricular systemic-to-
pulmonary shunt, thus inducing right ventricular pressure and volume overload and pulmonary
hypertension. It becomes symptomatic in infancy due to congestive heart failure and failure to
thrive. Diagnosis of CAVC might be suspected from electrocardiographic and chest X-ray findings.
Echocardiography confirms it and gives anatomical details. Over time, pulmonary hypertension
becomes irreversible, thus precluding the surgical therapy. This is the reason why cardiac
catheterisation is not mandatory in infants (less than 6 months) but is indicated in older patients if
irreversible pulmonary hypertension is suspected. Medical treatment (digitalis, diuretics,
vasodilators) plays a role only as a bridge toward surgery, usually performed between the 3rd and
6th month of life.
Disease name and synonyms
Complete atrioventricular canal (CAVC); Common atrio-
ventricular canal; Complete atrioventricular septal defect.
European paediatric cardiac code
Reference of Complete atrioventricular canal is 06.06.09.
Definition
CAVC is a complex cardiac malformation characterised by
a variable deficiency of the atrioventricular area (crux
cordis) in the developing heart. The malformation
involves the atrial, ventricular and atrioventricular septa
and both atrioventricular valves.
Diagnosis criteria
Diagnosis of CAVC might be clinically suspected in
patients presenting in the first few months of life with
congestive heart failure, cardiomegaly on chest X-ray and
left axis deviation, bi-atrial enlargement and bi-ventricu-
lar pressure and volume overload on electrocardiogram
(ECG). Echocardiography is the key tool for the diagnosis
and anatomic classification of this malformation. It
shows the ostium primum atrial septal defect, with the
underlying common atrioventricular valve, and the defect
of the ventricular septal inflow (Figure 1).
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The anatomic subgroups (Rastelli's type A, B and C) can
be classified on the basis of the chordal insertions and
morphology of the superior bridging leaflet of the com-
mon atrioventricular valve (Table 1). Similarly, a thor-
ough echocardiographic examination shows the degree of
dysfunction of the common atrioventricular valve, as well
as the presence of associated cardiac malformations. To
date, cardiac catheterisation is not considered as manda-
tory for the diagnosis, but can be indicated in patients
older than 6 months with suspected irreversible pulmo-
nary hypertension. Cardiac catheterisation allows accu-
rate quantification of the left-to-right shunt as well as
assessment of the degree of pulmonary hypertension and
the reversibility of the pulmonary artery resistances by
hyperoxia and/or pharmacological tests. On left ventricu-
lar angiography, the appearance of the "gooseneck
deformity" of the left ventricular outflow tract is peculiar
of atrioventricular canal malformations.
Differential diagnosis
Differential diagnosis of CAVC involves mainly the unre-
strictive ventricular septal defect, associated or not to
mitral valve insufficiency. The clinical picture of conges-
tive heart failure, the bi-atrial and bi-ventricular overload
on ECG, and cardiomegaly and pulmonary congestion on
chest X-ray are common to the ventricular septal defect.
However, on ECG the left axis deviation of QRS at -30°,
usually combined with a various degree of right bundle
branch block, appears to be suggestive of CAVC. Eventu-
ally, the echocardiographic examination is the corner-
stone for diagnosis and is of help for that of any further
associated cardiac malformation.
Epidemiology
CAVC accounts for about 3% of all cardiac malforma-
tions. Atrioventricular canal occurs in two out of every
10,000 live births. Both sexes are equally affected, with a
slightly higher frequency in female (female/male ratio
1.3/1) and a striking association with Down syndrome
was found [1,2].
Pathology
The complete form of AVC shows an ostium primum
atrial septal defect, a common atrioventricular valve and a
variable deficiency of the interventricular septum inlet
[2,3]. This anatomic arrangement gives a scooped out
appearance to the ventricular inlet and a long and narrow
morphology to the left ventricular outlet. The key finding
for the anatomic classification in type A, B or C of this
malformation is the morphology of the common atriov-
entricular valve [4]. It is basically built-up of five leaflets
(superior, inferior, mural in the right and left ventricle and
antero-superior), embryologically derived from the origi-
nal endocardial cushions. The size of the antero-superior
leaflet is reciprocal with the extent of bridging of the supe-
rior leaflet. In type A, the superior bridging leaflet is
almost completely adherent to the left ventricle and is
firmly attached on the ventricular septum by multiple
chordal insertions. In type B, the superior bridging leaflet
is larger and overhangs the ventricular septum more than
in type A, attached over it by an anomalous papillary mus-
cle of the right ventricle. In type C, the superior bridging
leaflet is larger and is not attached to the ventricular sep-
tum (free-floating leaflet), thus provoking an unrestricted
interventricular communication. Type A CAVC is most
frequently associated with left-sided obstructions. Type B
Echocardiography of Complete atrioventricular canal Figure 1
Echocardiography of Complete atrioventricular canal.
Table 1: Anatomic classification of CAVC [4]
Type A
the superior bridging leaflet is almost completely adherent to the left ventricle and is firmly attached on the ventricular septum by multiple chordal 
insertions
Type B
the superior bridging leaflet is attached over the ventricular septum by an anomalous papillary muscle of the right ventricle
Type C
the superior bridging leaflet is not attached to the ventricular septum (free-floating leaflet)Orphanet Journal of Rare Diseases 2006, 1:8 http://www.OJRD.com/content/1/1/8
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is the least common form of atrioventricular canal. Type C
is often associated with other complex cardiac malforma-
tions such as tetralogy of Fallot. Other cardiac malforma-
tions are the left ventricular inflow and outflow
obstructions, mainly due to anomaly of the left compo-
nent of the common atrioventricular valve, and to ven-
tricular imbalance, with right ventricular dominance.
These additional left-sided anomalies are more frequent
in children without Down syndrome [5-7].
A "partial variant" of AVC exists (also known as ostium
primum atrial septal defect). Nevertheless, some authors
observed how "complete" and "partial" are inappropriate
adjectives to describe these variants [8-11]. Indeed,
despite the septal deficiency, the essence of the atrioven-
tricular canal malformations (or atrioventricular septal
defects) is the common atrioventricular junction [8-11].
Within this common junction, there may be a common
atrioventricular valvar orifice (so called "complete"
defects), or separate right and left valvar orifices for the
right and left ventricles (so called "partial" defects).
The space between the left ventricular components of the
superior and inferior bridging leaflets is traditionally
called "cleft". Morphological studies suggested that this
gap functions as a commissure, even though it is not sup-
ported by a papillary muscle [12]. In Rastelli's type A mal-
formation, the space in the common anterior leaflet is
also called "cleft". Again, it potentially functions as a com-
missure, being supported by the medial papillary muscle
of the right ventricle [12].
Clinical description
Symptoms occur in infancy as a result of high pulmonary
blood flow associated with pulmonary hypertension, and
often complicated by insufficiency of the common atriov-
entricular valve. Failure to thrive, as well as congestive
heart failure and frequent pulmonary infections, are
invariably seen. Thus, patients with CAVC often have
feeding problems and are virtually symptomatic in the
first few months of life. Signs of congestive heart failure
consist in feeding difficulties, excessive sweating, tachy-
cardia, tachypnea, subcostal and intercostal retractions,
mild wheezing, hepatic enlargement and poor peripheral
blood perfusion [13]. If a significant regurgitation of the
common atrioventricular valve is present, a systolic car-
diac murmur and gallop rhythm are frequently heard.
Over time, irreversible pulmonary hypertension develops,
improving the signs of congestive heart failure but wors-
ening tolerance to effort. When pulmonary artery resist-
ances becomes higher than systemic artery resistances, the
intracardiac shunt reverses and cyanosis develops, further
decreasing the exercise capacity.
Natural history
Half of children with untreated CAVC die in the first year
of life [1,13,14]. The main cause of death in infancy is
either heart failure or pneumonia. In surviving patients
with unrepaired complete atrioventricular canal, irrevers-
ible pulmonary vascular disease becomes increasingly
common, and affects virtually all patients older than 2
years of age [15]. Long-term prognosis in patients with
irreversible pulmonary hypertension is poor.
Treatment
Medical treatment
Medical therapy aims to improve the signs and symptoms
of congestive heart failure. Thus, it should be just consid-
ered as a bridge toward surgery. Pharmacological therapy
is based on digitalis, diuretics and vasodilators. Oral ther-
apy with digoxin starts with a loading dose of 20–40 µg/
kg (depending on the patient's age, from premature to
child) in 3 doses over 24 h, continuing with a mainte-
nance dose of 8–10 µg/kg/day in 2 doses. Diuretic therapy
is mainly based on furosemide, at the dose of 1–6 mg/kg/
day, and spironolactone, at the dose of 2–3.5 mg/kg/day.
Vasodilator therapy consists chiefly in the angiotensin
converting enzyme inhibitors, captopril (0.5–3 mg/kg/
day, tid) or enalapril (0.1–0.4 mg/kg/day, bid). Increasing
interest is raising regarding the utilisation and potential
benefits of beta-blockers (mainly, propanolol, metopro-
lol and carvedilol) in infants and children heart failure
due to congenital heart defects with left to right shunt,
although long-term results are needed. Finally, the new
generation of pulmonary vasodilators dramatically
improved the post-operative course and the overall prog-
nosis of the patients [16].
Surgical treatment
Surgical treatment is preferably scheduled before 6–12
months of life. Generally, the great majority of surgeons
perform the repair between the 3rd (to reduce the inci-
dence of pulmonary hypertension crisis) and the 6th
month of life. Surgical palliation with pulmonary artery
banding is now seldom indicated in high-risk infants
(very low weight and/or in critical conditions). It reduces
the pulmonary artery flow and pressure, so controlling the
congestive heart failure, promoting the patient's growth
and preventing the development of pulmonary vascular
disease, but is contra-indicated in patients with severe atri-
oventricular valve regurgitation. However, more fre-
quently complete intracardiac repair is indicated. It
consists in closure of the intracardiac communications
with a single or separate atrial and ventricular patches, in
construction of two separate and competent atrioventricu-
lar valves using the available tissue from the common atri-
oventricular valve leaflet, and in repair of associated
cardiac anomalies [13,17,18]. An alternative technique,
using a direct suture closure of the ventricular component,Orphanet Journal of Rare Diseases 2006, 1:8 http://www.OJRD.com/content/1/1/8
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accompanied by pericardial patch closure of the atrial
component, was first suggested by Wilcox et al. [19].
Depending on the specific anatomic findings (i.e., in
absence of severe "scooping" of the ventricular septum),
the lesion can be adequately repaired in most instances by
sewing down the bridging leaflets to the crest of the ven-
tricular septum.
Risk factors for surgical repair include the patient's age,
the severity of pre-operative common valve incompe-
tence, the presence of associated cardiac malformations
and the degree of the functional class [20][21][22][23].
The prognosis is directly related to the repair of the left A-
V valve [20]. To date, the overall mortality for primary
repair of CAVC is below 5–10%. Long-term survival is
good and in 80%–95% of cases there is no need for reop-
eration [18,21]. Of note, the closure of the cleft results in
longer times before a reoperation is necessary [24].
Aetiology
Formation of atrioventricular canal results from complex
interactions of components of the extracellular matrix.
Septation of the atrioventricular junction is brought about
by downgrowth of the primary atrial septum, fusion of the
endocardial cushions and forward expansion of the ves-
tibular spine between atrial septum and cushions [3].
Thus, atrioventricular canal can result from arrest or inter-
ruption of the normal endocardial cushion development
[25,26]. Experimental studies showed that environmental
teratogens [27] or endogenous metabolic abnormalities
[28] might result in abnormal development of the atriov-
entricular area, which may be due to altered apoptosis of
these forming cells [29]. Trancription factors (TBX2,
Foxp1 among the others) and signal pathways (ErbB
receptor activation) involved during embryogenesis in the
heart development process have been strongly suggested
to have a role in atrioventricular septation [30-32].
Epidemiological studies [2,33] showed that complete atri-
oventricular canal tends to be associated with chromo-
somal abnormalities, mainly Down syndrome [10], del
[8p] syndrome [34], trisomy 9, trisomy 18 [6,35]. Further-
more, CAVC with Down syndrome has been less fre-
quently associated with left cardiac anomalies than the
isolated form [5,7]. In this latter subset of patients, the
analysis of potential risk factors revealed an association
with maternal diabetes and antitussive drugs [36]. How-
ever, in patients with Down syndrome and complete AVC,
no strong association other than maternal age has been
found. In the asplenia syndrome, the CAVC is virtually
always present, while it occurs in about 25% of patients
with polisplenia [37]. An association between nonchro-
mosomal defects and atrioventricular malformations
have also been reported [5,6].
Genetic counselling and antenatal diagnosis
In the presence of a single affected family member, the
risk of siblings of inheriting the defect is about 2%, with a
higher percentage for the offspring of an affected parent.
Concordance for atrioventricular malformations among
siblings is higher than for other types of congenital heart
defects [38].
Due to the strict association with Down syndrome and
other chromosomal anomalies, genetic antenatal counsel-
ling after the foetal echocardiographic diagnosis of CAVC
is mandatory. At present, prenatal diagnosis of CAVC has
been associated with a 58% risk of aneuploidy, mainly tri-
somy 21 [39]. Again, due to the strong association
between chromosomal abnormalities and CAVC, when
this malformation seems isolated at antenatal echocardi-
ography, the risk of trisomy 21 is significantly higher than
when other associated cardiac lesions are diagnosed.
References
1. Flyer DC: Endocardial cushion defects.  In Nadas' Pediatric Cardi-
ology Edited by: Fyler DC. Hanley & Belfus, Inc., Philadelphia;
1992:577-589. 
2. Ferencz C, Loffredo CA, Correa-Villasenor A, Wilson PD: Genetic and
Environmental Risk Factors of Major Cardiovascular Malformations: The
Baltimore-Washington Infant Study 1981–1989 Edited by: Anderson RH
Armonk N. Futura Publishing Co Inc; 1997. 
3. Kim JS, Viragh S, Moorman AF, Anderson RH, Lamers WH: Devel-
opment of the myocardium of the atrioventricular canal and
the vestibular spine in the human heart.  Circ Res 2001,
88:395-402.
4. Rastelli GC, Kirklin JW, Titus JL: Anatomic observations on com-
plete form of common atrioventricular canal with special
reference to atrioventricular valves.  Mayo Clinic Proc 1966,
41:296.
5. Marino B, Vairo U, Corno A, Nava S, Guccione P, Calbro R, Marcel-
letti C: Atrioventricular canal in Down syndrome. Prevalence
of associated cardiac malformations compared with patients
without Down syndrome.  Am J Dis Child 1990, 144:1120-1122.
6. Digilio MC, Marino B, Toscano A, Giannotti A, Dallapiccola B: Atri-
oventricular canal defect without Down syndrome: a heter-
ogeneous malformation.  Am J Med Genet 1999, 85:140-146.
7. De Biase L, Di Ciommo V, Ballerini L, Bevilacqua M, Marcelletti C,
Marino B: Prevalence of left-sided obstructive lesions in
patients with atrioventricular canal without Down's syn-
drome.  J Thorac Cardiovasc Surg 1986, 91:467-479.
8. Penkoske PA, Neches WH, Anderson RH, Zuberbuhler JR: Further
observations on the morphology of atrioventricular septal
defects.  J Thorac Cardiovasc Surg 1985, 90:611-622.
9. Falcão S, Daliento L, Ho SY, Rigby ML, Anderson RH: Cross sec-
tional echocardiographic assessment of the extent of the
atrial septum relative to the atrioventricular junction in atri-
oventricular septal defect.  Heart 1999, 81:199-205.
10. Ebels T, Ho SY, Anderson RH, Meijboom EJ, Eijgelaar A: The surgi-
cal anatomy of the left ventricular outflow tract in atrioven-
tricular septal defect.  Ann Thorac Surg 1986, 41:483-488.
11. Anderson RH, Ho SY, Falcao S, Daliento L, Rigby ML: The diagnos-
tic features of atrioventricular septal defect with common
atrioventricular junction.  Cardiol Young 1998, 8:33-49.
12. Anderson RH, Zuerbuhler JR, Penkoske PA, Neches WH: Of clefts,
commisssures, and things.  J Thorac Cardiovasc Surg 1985,
90:605-610.
13. Marsico F, Violini R, Calabrò R, et al.:  Atrioventricular septal
defects. Natural history and clinical picture.  In Pediatric Cardi-
ology – Atrioventricular Septal Defects Edited by: Quero Jimenez M,
Arteaga Martinez M. Ediciones Norma, Madrid; 1988:194-203. 
14. Santoro G, Marino B, Di Carlo D, Formigari R, Santoro G, Marcelletti
C, Pasquini L: Patient selection for repair of complete atriov-Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
Orphanet Journal of Rare Diseases 2006, 1:8 http://www.OJRD.com/content/1/1/8
Page 5 of 5
(page number not for citation purposes)
entricular canal guided by echocardiography.  Eur J Cardio-Tho-
rac Surg 1996, 10:439-442.
15. Berger TJ, Blackstone EH, Kirklin JW: Survival and probability of
cure without and with surgery in complete atrioventricular
canal.  Ann Thorac Surg 1979, 27:104-111.
16. Trachte AL, Lobato EB, Urdaneta F, Hess PJ, Klodell CT, Martin TD,
Staples ED, Beaver TM: Oral sildenafil reduces pulmonary
hypertension after cardiac surgery.  Ann Thorac Surg 2005,
79:194-197.
17. Crawford FA Jr, Stroud MR: Surgical repair of complete atriov-
entricular septal defect.  Ann Thorac Surg 2001, 72:1621-1628.
18. Atrioventricular canal defect.  In Cardiac Surgery Edited by: Kirklin
JW, Barratt-Boyes BG. Churchill Livingstone, UK; 1993:749-825. 
19. Wilcox BR, Jones DR, Frantz EG, Brink LW, Henry GW, Mill MR,
Anderson RH: Anatomically sound, simplified approach to
repair of "complete" atrioventricular septal defect.  Ann Tho-
rac Surg 1997, 64:487-493.
20. Boening A, Scheewe J, Heine K, Hedderich J, Regensburger D,
Kramer HH, Cremer J: Long term results after surgical correc-
tion of atrioventricular septal defects.  Eur J Cardiothorac Surg
2002, 22:167-173.
21. Merrill WH, Hoff SJ, Bender HW Jr: The surgical treatment of
atrioventricular septal defects.  In Pediatric Cardiac Surgery 2nd
edition. Edited by: Mavroudis C, Backer CL. Mosby Year Book, Inc. St
Louis, Missouri, USA; 1994:225-237. 
22. Gunther T, Mazzitelli D, Haehnel CJ, Holper K, Sebening F, Meisner
H: Long-term results after repair of complete atrio-ventricu-
lar septal defects: analysis of risk factors.  Ann Thorac Surg 1998,
65:754-759.
23. Najm HK, Coles JG, Endo M, Stephens D, Rebeyka IM, Williams WG,
Freedom RM: Complete atrioventricular septal defects:
results of repair, risk factors and freedom from reoperation.
Circulation 1997, 96:311-315.
24. Bando K, Turrentine MW, Sun K, Sharp TG, Ensing GJ, Miller AP, Kes-
ler KA, Binford RS, Carlos GN, Hurwitz RA, et al.: Surgical man-
agement of complete atrioventricular septal defects. A
twenty-year experience.  J Thorac Cardiovac Surg 1995,
110:1543-1552.
25. de la Cruz MV, Markwald RR: Living Morphogenesis of the Heart Edited
by: Markwald R, de La Cruz M, Markwald R. Springer-Verlag; New
York; 1998:223. 
26. Pierpont ME, Markwald RR, Lin AE: Genetic aspects of atrioven-
tricular septal defects.  Am J Med Genet 2000, 974:289-296.
27. Bouman HG, Broekhuizen ML, Baasten AM, Gittenberger-de Groot
AC, Wenink AC: Diminished growth of atrioventricular cush-
ion tissue in stage 24 retinoic-treated chicken embryos.  Dev
Dyn 1998, 213:50-58.
28. Santoro G, Ambrosio G, Formigari R, Marcelletti C, Chiariello M,
Marino B: Low level of myocardial Superoxide Dismutase in
patients with atrioventricularcanal.  J Am Coll Cardiol 1994,
23:-306A.
29. Saphier CJ, Yeh J: Altered apoptosis levels in hearts of human
fetuses with Down syndrome.  Am J Obstet Gynecol 1998,
179:962-965.
30. Harrelson Z, Kelly RG, Goldin SN, Gibson-Brown JJ, Bollag RJ, Silver
LM, Papaioannou VE: Tbx2 is essential for patterning the atrio-
ventricular canal and for morphogenesis of the outflow tract
during heart development.  Development 2004, 131:5041-5052.
31. Wang B, Weidenfeld J, Lu MM, Maika S, Kuziel WA, Morrisey EE,
Tucker PW: Foxp1 regulates cardiac outflow tract, endocar-
dial cushion morphogenesis and myocyte proliferation and
maturation.  Development 2004, 131:4477-4487.
32. Camenisch TD, Schroeder JA, Bradley J, Klewer SE, McDonald JA:
Heart-valve mesenchyme formation is dependent on
hyaluronan-augmented activation of ErbB2-ErbB3 recep-
tors.  Nat Med 2002, 8:850-855.
33. Carmi R, Boughman JA, Ferencz C: Endocardial cushion defect:
further studies of "isolated" versus "syndromic" occurrence.
Am J Med Genet 1992, 43:569-575.
34. Marino B, Reale A, Giannotti A, Digilio MC, Dallapiccola B: Nonran-
dom association of atrioventricular canal and del(8p) syn-
drome.  Am J Med Genet 1992, 42:424-427.
35. Francalanci P, Marino B, Boldrini R, Abella R, Iorio F, Bosman C: Mor-
phology of the atrioventricular valve in asplenia syndrome: a
peculiar type of atrioventicular canal defect.  Cardiovasc Pathol
1996, 5:145-151.
36. Loffredo CA, Hirata J, Wilson PD, Ferencz C, Lurie IW: Atrioven-
tricular septal defects: possible etiologic differences between
complete and partial defects.  Teratology 2001, 63:87-93.
37. Rose V, Izukawa T, Moes CA: Syndromes of asplenia and polys-
plenia. A review of cardiac and non-cardiac malformations in
60 cases with special reference to diagnosis and prognosis.  Br
Heart J 1975, 37:840-852.
38. Nora JJ, Nora AH: Maternal transmission of congenital heart
diseases: new recurrence risk figures and the questions of
cytoplasmic inheritance and vulnerability to teratogens.  Am
J Cardiol 1987, 59:459-463.
39. Delisle MF, Sandor GG, Tessier F, Farquharson DF: Outcome of
fetuses diagnosed with atrioventricular septal defect.  Obstet
Gynecol 1999, 94:763-767.